Ureteral Stents Market is expected to grow at a CAGR of 5.8% during the forecast period 2022-2029. As per Priority Exploration, the worldwide red biotechnology market size is anticipated to hit around US$ 510 billion by 2027 from an estimated at US$ 322 billion out of 2022. The North America region has the highest market share in the Ureteral Stents Market, and it is further continuing its dominance during the forecast period.
Our research report gives wide perceptions of the latest trends and development prospects of the market analysis, detailed segmentation analysis, volume, size, share, growth drives, and opportunities in the market. In-depth regional and country-level illustration of the competitive landscape depends on several phases and status of clinical trials over the prominent economies of the globe, and also the report contains a number of major companies profiled in the relevant market.
To Download free sample @ Click Here
The rising number of kidney transfers and the developing geriatric populace fuel the development of the worldwide market.
The rising number of kidney transfers is supposed to drive the market. For example, as per the Worldwide Observatory on Gift and Transplantation, in 2020, there were more than 80,926 kidneys gave, and in 2021 around 98,349 kidneys were given. The middle sit tight time for a singular’s most memorable kidney relocate is around 3.6 years and fluctuates relying upon similarity, wellbeing, and accessibility of organs. As per the report distributed by NHS Blood and Relocate, which works as a team with NHS Britain, the dynamic holding up list starting around 24 February 2022 has 4,658 patients hanging tight for a kidney, including 98 youngsters. This number is supposed to rise. Subsequently, the developing number of renal transfers and raising worries connected with urological brokenness have flooded the interest for ureteral stents for post-employable accommodation.
Besides, the developing geriatric populace is supposed to drive the worldwide ureteral stents market. For example, according to World Wellbeing Association, the quantity of individuals matured 65 is supposed to ascend from an expected 1 billion of every 2020 to 1.4 billion out of 2030; the world’s geriatric populace will twofold (2.1 billion) by 2050 and somewhere in the range of 2020 and 2050, the people matured 80 years or more established will reach to 426 million, with the majority of the expansion in non-industrial nations. This expansion in geriatrics will be reflected by the ascent in clinical issues, for example, kidney stones. It requires facilitated care by numerous strengths, with geriatricians and nephrologists assuming an imperative part in treating these patients.
By Product Type
Double pigtail stents
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Major Companies Covered:
Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, Coloplast Ltd., C. R. Bard, Inc., Medline Industries, Inc., Allium Medical Solutions Ltd, Penn Medical A/S, Teleflex Incorporated, and Olympus Corporation.
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States